TABATHA FANT: Open Payments
NPI 1578140570 · GRENADA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 18 payments from 6 companies in 2025. Trend: 2023 $813 · 2024 $465 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $288 |
| Bard Peripheral Vascular, Inc. | 1 | $78 |
| Novo Nordisk Inc | 3 | $59 |
| Amgen Inc. | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: AIRSUPRA, RotarexS 6 F x 135 cm, BREZTRI, EVENITY, Rybelsus, GVOKE HYPOPEN, KISUNLA, FARXIGA.
Industry payments across MS — which companies pay providers there.
